Droxidopa management by an integrated health-system specialty pharmacy team
- 13 June 2022
- journal article
- research article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 62 (6) , 1904-1911
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin accessMental Health Clinician, 2021
- Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotensionAutonomic Neuroscience, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Six‐Month Use of Droxidopa for Neurogenic Orthostatic HypotensionMovement Disorders Clinical Practice, 2019
- Integrated analysis of droxidopa trials for neurogenic orthostatic hypotensionBMC Neurology, 2017
- Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotensionJournal of the American Society of Hypertension, 2016
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Neurogenic Orthostatic HypotensionCirculation, 2009